沃華醫藥(002107.SZ):心可舒片中選全國中成藥採購聯盟集中帶量採購
格隆匯7月7日丨沃華醫藥(002107.SZ)公佈,2023年7月5日,全國中成藥聯合採購辦公室(“聯合採購辦公室”)發佈了《全國中成藥聯盟採購公吿(第4號)》,公司產品心可舒片中選。此次集中帶量採購由聯合採購辦公室牽頭,代表全國各省、直轄市、自治區(除湖南省、福建省)開展中成藥及相關藥品集中帶量採購,中選產品為心可舒片,規格為每片重0.31g,72片/盒(報價代表品),中選價格18.83元/盒。
心可舒片是國家基藥目錄產品、醫保甲類產品,是公司四大獨家支柱產品之一。本次中選價格與原基準價相比有較大幅度下降,可能對銷售業績造成一定壓力,但有利於提高藥品可及性、加速產品准入、提高品牌影響力,也有利於減輕患者用藥負擔。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.